Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(8%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_4
1
8%
Ph not_applicable
6
50%
Ph phase_2
1
8%
Ph phase_1
2
17%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(5)

Detailed Status

unknown5
Completed4
Withdrawn2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 21 (10.0%)
Phase 41 (10.0%)
N/A6 (60.0%)

Trials by Status

recruiting18%
unknown542%
withdrawn217%
completed433%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
12